REFERENCES
- Anderson W. H., Fitzgerald C. Q., Manasco P. K. Current and future applications of pharmacogenomics. New Horizons 1999; 7(2)262–269
- Wang D. G., Fan J. B., Siao C. J., Berno A., Young P., Sapolsky R., et al. Large-scale identification, mapping and genotyping of single-nucleotidepolymorphisms in the human genome. Science 1998; 280: 1077–1082
- Marshall E. Drug firms to create public database of genetic mutations. Science 1999; 284: 406–407
- Evans W. E., Relling M. V. Pharmacogenomics: Translating functional genomics into rationaltherapeutics. Science 1999; 286: 487–491
- Elston R. Linkage and association. Genet. Epidemiol. 1998; 15: 565–576
- Lai E., Riley J., Purvis I., Roses A. A 4-Mb high-density single nucleotide polymorphism-based maparound human APOE. Genomics 1998; 54: 31–38
- Reilly P. R., Boshar M. F., Holtzman S. H. Ethical issues in genetic research: Disclosure and informedconsent. Nature Genet. 1997; 15: 16–20